Ademi LLP Investigates Claims of Securities Fraud against Akero Therapeutics, Inc.
Akero(AKRO) Prnewswire·2024-04-03 06:05
MILWAUKEE, April 2, 2024 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Akero (Nasdaq: AKRO). The investigation results from inaccurate statements Akero may have made regarding its business operations and prospects. Click here to learn more about the investigation: https://www.ademilaw.com/case/akero-therapeutics-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. The investigation focuses on Akero's representations regarding its Phas ...